TrialArthritis research & therapy2020

Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes.

Cem Gabay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.